Grants
RESEARCH GRANT
CABRI is fully dedicated to actively researching new treatments for rare diseases. To support this endeavor, we offer research grants to specific principal investigators at academic research institutions who have a plan to extend the clinical or pre-clinical development of our mission.
Eligible applicants include domestic and international researchers alike, as well as domestic and international group collaborations. Research grants are open to investigators of any career stage who are capable of leading an independent research study and supervising personnel. Funds must be used solely for research. CABRI does not fund institutional overhead costs.
Applications may be submitted at any time during the year.
To apply for a CABRI research grant, please use our Research Proposal Application.
2024 Grant Recipients
$80,000 – Elias Arner at Karolinska Institute – Understanding and targeting of selenoproteins in health and disease
$ 77,070 – Alan Brash at Vanderbilt University – Uncovering the role of the 12R-lipoxygenase pathway and the covalent binding of lipids in the skin permeability barrier
2023 Grant Recipients
$120,000 – Stefan Zwingenberger at University of Dresden – Improvement of bone regeneration and implant ingrowth in osteoporotic bone by treatment with a prostaglandin receptor agonist
$ 73,399 – Alan Brash at Vanderbilt University – Uncovering the role of the 12R-lipoxygenase pathway and the covalent binding of lipids in the skin permeability barrier
$70,000 – Makoto Murakami at University of Tokyo – Development and application of agents that target specific sPLA2 isoforms based on the sPLA2 metabolome map
$25,000 – Forest Baker at The University of Arizona -A Novel Small Molecule sPLA2-X Inhibitor for the Treatment of Diffuse Large B Cell Lymphoma and Multiple Myeloma
$80,000 – Elias Arner at Karolinska Institute – Understanding and targeting of selenoproteins in health and disease
2022 Grant Recipients
$69,500.00 – Miriam Greenberg at Wayne State University – Evaluation of irisin as a potential treatment for impaired myogenesis in Barth syndrome
$125,214.28 – Laura Goodrich at Colorado State University – Orthopedic Research Center Project Title – KMN159 bone stimulation to enhance fracture repair: a pilot study
$100,000 – Ginger Milne at Vanderbilt University – Characterization of the SPM Metabolome for the Accurate and Complete Assessment of Endogenous SPM Formation
$71,500.00 – Sven-Erik Dahlen at Karolinska. The study tests the hypothesis that mast cell-dependent bronchoconstriction in subjects with asthma is abolished by the combined inhibition of histamine, cysteinyl-leukotrienes, and PGD2.
$75k-Dr. Craig Wheelock at the Karolinska Institute, Research entitled: “Inhibition of the soluble epoxide hydrolase to treat acute respiratory distress syndrome (ARDS) in COVID-19 patients”.